share_log

Doximity analyst ratings

Doximity analyst ratings

Doximity分析師評級
Benzinga Analyst Ratings ·  2022/05/19 18:42
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
05/19/2022 45.07% Piper Sandler $81 → $44 Maintains Overweight
05/18/2022 71.45% Guggenheim $70 → $52 Maintains Buy
05/18/2022 51.67% Jefferies $78 → $46 Maintains Buy
05/18/2022 31.88% Raymond James $60 → $40 Maintains Outperform
05/18/2022 15.4% Morgan Stanley $55 → $35 Maintains Equal-Weight
05/18/2022 48.37% Baird $68 → $45 Maintains Outperform
05/18/2022 48.37% Needham $70 → $45 Maintains Buy
05/18/2022 120.9% SVB Leerink $72 → $67 Maintains Outperform
04/07/2022 130.79% Guggenheim → $70 Initiates Coverage On → Buy
04/04/2022 81.34% B of A Securities → $55 Initiates Coverage On → Neutral
03/23/2022 81.34% Morgan Stanley $62 → $55 Maintains Equal-Weight
02/11/2022 143.98% Goldman Sachs → $74 Initiates Coverage On → Buy
02/09/2022 97.82% Raymond James $80 → $60 Maintains Outperform
02/09/2022 130.79% Needham $90 → $70 Maintains Buy
12/17/2021 91.23% Morgan Stanley $72 → $58 Maintains Equal-Weight
12/14/2021 97.82% JP Morgan $70 → $60 Downgrades Neutral → Underweight
12/02/2021 157.17% Jefferies → $78 Initiates Coverage On → Buy
11/17/2021 176.95% Baird → $84 Initiates Coverage On → Outperform
11/10/2021 163.77% Raymond James $62 → $80 Maintains Outperform
11/10/2021 196.74% Needham $62 → $90 Maintains Buy
11/10/2021 137.39% SVB Leerink $65 → $72 Maintains Outperform
08/31/2021 134.09% Morgan Stanley $52 → $71 Maintains Equal-Weight
08/26/2021 130.79% JP Morgan → $70 Downgrades Overweight → Neutral
08/11/2021 104.42% Raymond James $60 → $62 Maintains Outperform
07/19/2021 71.45% Morgan Stanley → $52 Initiates Coverage On → Equal-Weight
07/19/2021 97.82% Raymond James → $60 Initiates Coverage On → Outperform
07/19/2021 104.42% Needham → $62 Initiates Coverage On → Buy
07/19/2021 — William Blair Initiates Coverage On → Outperform
07/19/2021 111.01% Canaccord Genuity → $64 Initiates Coverage On → Buy
07/19/2021 114.31% SVB Leerink → $65 Initiates Coverage On → Outperform
07/19/2021 124.2% Piper Sandler → $68 Initiates Coverage On → Overweight
07/19/2021 18.69% Goldman Sachs → $36 Initiates Coverage On → Neutral
07/19/2021 97.82% JP Morgan → $60 Initiates Coverage On → Overweight
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
05/19/2022 45.07% 派珀·桑德勒 $81 → $44 維護 超重
05/18/2022 71.45% 古根海姆 $70 → $52 維護 買
05/18/2022 51.67% 傑富瑞 $78 → $46 維護 買
05/18/2022 31.88% 雷蒙德·詹姆斯 $60 → $40 維護 跑贏大盤
05/18/2022 15.4% 摩根士丹利 $55 → $35 維護 等重
05/18/2022 48.37% 貝爾德 $68 → $45 維護 跑贏大盤
05/18/2022 48.37% 李約瑟 $70 → $45 維護 買
05/18/2022 120.9% SVB Leerink $72 → $67 維護 跑贏大盤
04/07/2022 130.79% 古根海姆 → $70 開始承保 →購買
04/04/2022 81.34% B of A證券 → $55 開始承保 →中性
03/23/2022 81.34% 摩根士丹利 $62 → $55 維護 等重
02/11/2022 143.98% 高盛 → $74 開始承保 →購買
02/09/2022 97.82% 雷蒙德·詹姆斯 $80 → $60 維護 跑贏大盤
02/09/2022 130.79% 李約瑟 $90 → $70 維護 買
12/17/2021 91.23% 摩根士丹利 $72 → $58 維護 等重
12/14/2021 97.82% 摩根大通 $70 → $60 評級下調 中性→減持
12/02/2021 157.17% 傑富瑞 → $78 開始承保 →購買
11/17/2021 176.95% 貝爾德 → $84 開始承保 →跑贏大盤
11/10/2021 163.77% 雷蒙德·詹姆斯 $62 → $80 維護 跑贏大盤
11/10/2021 196.74% 李約瑟 $62 → $90 維護 買
11/10/2021 137.39% SVB Leerink $65 → $72 維護 跑贏大盤
08/31/2021 134.09% 摩根士丹利 $52 → $71 維護 等重
08/26/2021 130.79% 摩根大通 → $70 評級下調 超重→中性
08/11/2021 104.42% 雷蒙德·詹姆斯 $60 → $62 維護 跑贏大盤
07/19/2021 71.45% 摩根士丹利 → $52 開始承保 →等重
07/19/2021 97.82% 雷蒙德·詹姆斯 → $60 開始承保 →跑贏大盤
07/19/2021 104.42% 李約瑟 → $62 開始承保 →購買
07/19/2021 — 威廉·布萊爾 開始承保 →跑贏大盤
07/19/2021 111.01% 卡納科特·格納奇 → $64 開始承保 →購買
07/19/2021 114.31% SVB Leerink → $65 開始承保 →跑贏大盤
07/19/2021 124.2% 派珀·桑德勒 → $68 開始承保 →超重
07/19/2021 18.69% 高盛 → $36 開始承保 →中性
07/19/2021 97.82% 摩根大通 → $60 開始承保 →超重

Doximity Questions & Answers

多氧性問題與解答

What is the target price for Doximity (DOCS)?
Doximity(DOCS)的目標價是多少？

The latest price target for Doximity (NYSE: DOCS) was reported by Guggenheim on May 18, 2022. The analyst firm set a price target for $52.00 expecting DOCS to rise to within 12 months (a possible 71.45% upside). 32 analyst firms have reported ratings in the last year.

古根海姆於2022年5月18日報道了Doximity(紐約證券交易所代碼：DOCS)的最新目標價。這家分析公司將目標價定為52.00美元，預計DOCS將在12個月內上漲至71.45%。去年有32家分析公司公佈了評級。

What is the most recent analyst rating for Doximity (DOCS)?
Doximity(DOCS)的最新分析師評級是多少？

The latest analyst rating for Doximity (NYSE: DOCS) was provided by Guggenheim, and Doximity maintained their buy rating.

古根海姆對Doximity(紐約證券交易所代碼：DOCS)的最新分析師評級為買入，Doximity維持買入評級。

When is the next analyst rating going to be posted or updated for Doximity (DOCS)?
Doximity(DOCS)的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Doximity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Doximity was filed on May 18, 2022 so you should expect the next rating to be made available sometime around May 18, 2023.

分析師在進行了廣泛的研究後得出了股票評級，其中包括查閲公共財務報表，與Doximity的高管和客户交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Doximity的上一次評級是在2022年5月18日提交的，所以你應該預計下一次評級將在2023年5月18日左右的某個時候公佈。

Is the Analyst Rating Doximity (DOCS) correct?
分析師評級Doximity(DOCS)正確嗎？

While ratings are subjective and will change, the latest Doximity (DOCS) rating was a maintained with a price target of $70.00 to $52.00. The current price Doximity (DOCS) is trading at is $30.33, which is out of the analyst's predicted range.

雖然評級是主觀的，會發生變化，但最新的Doximity(DOCS)評級保持不變，目標價在70.00美元到52.00美元之間。Doximity(DOCS)目前的交易價格為30.33美元，超出了分析師的預測區間。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論